WHO ICTRP trial
Effects of amino acids on nonalcoholic fatty liver disease
JPRN-jRCTs031210207 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-jRCTs031210207 |
|---|---|
| Public title | Effects of amino acids on nonalcoholic fatty liver disease |
| Scientific title | Effect of oral amino acid preparations on insulin resistance in nonalcoholic fatty liver disease: multicenter, randomized, double-blind comparative study |
| Primary sponsor | Ikejima Kenichi |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Conditions | Nonalcoholic fatty liver disease NAFLD, NASH;NAFLD, NASH |
| Interventions | Treatment Group: Glycine (3000 mg) given on 3 times daily for 2 weeks Control Group: Casein (3000 mg) given on 3 times daily for 2 weeks;Amino Acid |
| Registration date | Jul 27, 2021 |
| Target size | 52 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: